title: Breath Testing for Small Intestinal Bacterial Overgrowth: A Means to Enrich Rifaximin Responders in IBS Patients?
authors.affiliation: Department of Internal Medicine, Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan, USA.
authors.forename: Amit
authors.initials: A
authors.lastname: Gupta
authors.affiliation: Department of Internal Medicine, Division of Gastroenterology, University of Michigan Health System, Ann Arbor, Michigan, USA.
authors.forename: William D
authors.initials: WD
authors.lastname: Chey
mesh_terms: D000890:Anti-Infective Agents / Q000494:pharmacology; D001944:Breath Tests / Q000379:methods; D000069196:Gastrointestinal Microbiome / Q000187:drug effects*; D006801:Humans; D007421:Intestine, Small / Q000382:microbiology*; D043183:Irritable Bowel Syndrome / Q000188:drug therapy / Q000382:microbiology; D016032:Randomized Controlled Trials as Topic; D012294:Rifamycins / Q000494:pharmacology*; D000078262:Rifaximin
chemical_list: D000890:Anti-Infective Agents; D012294:Rifamycins; D000078262:Rifaximin